University HealthCare Alliance

August 13, 2020

Webinar | Diabetes & Substance Abuse in the Time of COVID-19

This activity will address the urgent needs of patients with type 1 and type 2 diabetes who require complex diabetes treatment in the primary care setting in the time of COVID-19 by empowering and increasing the capacity of primary care providers (PCPs) and clinics to safely and effectively manage underserved patients who do not have access to routine specialty care.

Led by a nationally/internationally renowned faculty team of diabetes experts (many of whom contribute to/co-author national guideline recommendations), this curriculum will spotlight various aspects of diabetes management for patients at high-risk for poor outcomes during the time of COVID-19. 

Date & Location
Wednesday, August 19, 2020
9:00am – 10:15am

Free webinar series offered at 9:00 am – 10:15 am (PT) every Wednesday.  Registration is required.

View all Project ECHO Diabetes COVID-19 series information and resources HERE(On-Demand Webinars available)

This Week’s Speaker
Diabetes & Substance Abuse in the Time of COVID-19
Justin Altschuler, MD, MS

AMA PRA Category 1 Credits™ (1.25 hours), Non-Physician Participation Credit (1.25 hours)

Target Audience
Specialties – All Specialties, Endocrinology & Metabolism, Family Medicine & Community Health, Internal Medicine, Pediatrics, Preventative Medicine & Nutrition

At the conclusion of this activity, participants will be able to:
  1. Describe why patients with diabetes are prone to substance use disorders (SUDs).
  2. Review implications of COVID-19 on SUDs in patients with diabetes.
  3. Identify the goals of care for patients with diabetes with active substance abuse disorders, and those in remission.
  4. Discuss pharmacologic and other treatments for SUDs in the time of COVID-19.
The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Read more